CHINA PHARMA HOLDINGS, INC. Line of Credit Facility, Interest Rate During Period
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Line of Credit Facility, Interest Rate During Period of 3.60% for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Debt
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2026-08-14
- 2025-09-30: Line of Credit Facility, Interest Rate During Period 9 month 3.60%.
- 2025-09-21: Line of Credit Facility, Interest Rate During Period 2.90%.
- 2025-06-30: Line of Credit Facility, Interest Rate During Period 6 month 3.60%.
- 2024-09-21: Line of Credit Facility, Interest Rate During Period 3.25%.
| Period end | Line of Credit Facility, Interest Rate During Period | Line of Credit Facility, Interest Rate During Period as first filed | Line of Credit Facility, Interest Rate During Period 6 month | Line of Credit Facility, Interest Rate During Period 9 month |
|---|---|---|---|---|
| 2025-09-30 | 3.60% 10-Q · filed 2025-11-12 | |||
| 2025-09-21 | 2.90% 10-Q · filed 2026-08-14 | |||
| 2025-06-30 | 3.60% 10-Q · filed 2025-08-14 | |||
| 2024-09-21 | 3.25% 10-Q · filed 2026-08-14 | |||
| 2023-09-25 | 12.00% 10-Q · filed 2026-08-14 | 3.35% 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |